Gentian Financial Statements From 2010 to 2026
| GENT Stock | NOK 58.80 0.20 0.34% |
Check Gentian Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gentian Diagnostics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Gentian financial statements analysis is a perfect complement when working with Gentian Diagnostics Valuation or Volatility modules.
Gentian |
Gentian Diagnostics AS Company Profit Margin Analysis
Gentian Diagnostics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Gentian Diagnostics Profit Margin | (0.27) % |
Most of Gentian Diagnostics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gentian Diagnostics AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Gentian Diagnostics AS has a Profit Margin of -0.2695%. This is 97.6% lower than that of the Healthcare sector and 97.68% lower than that of the Diagnostics & Research industry. The profit margin for all Norway stocks is 78.78% lower than that of the firm.
Gentian Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gentian Diagnostics's current stock value. Our valuation model uses many indicators to compare Gentian Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gentian Diagnostics competition to find correlations between indicators driving Gentian Diagnostics's intrinsic value. More Info.Gentian Diagnostics AS is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gentian Diagnostics' earnings, one of the primary drivers of an investment's value.About Gentian Diagnostics Financial Statements
Gentian Diagnostics investors utilize fundamental indicators, such as revenue or net income, to predict how Gentian Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Gentian Diagnostics AS researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, the United States. The company was founded in 2001 and is headquartered in Moss, Norway. GENTIAN DIAGNOSTIC is traded on Oslo Stock Exchange in Norway.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Gentian Stock
Gentian Diagnostics financial ratios help investors to determine whether Gentian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gentian with respect to the benefits of owning Gentian Diagnostics security.